Track the Ypsomed Holding AG share price and the full directors' dealings record of the company, a publicly traded company based in Switzerland. Shares trade on the CH market, under the supervision of SIX SER. Operating in the Health Care sector, Ypsomed Holding AG has recorded 16 reports. Market capitalisation: €5.2bn. The latest transaction was disclosed on 24 July 2026 (Sale). Every trade is accessible without an account.
16
Insider Decl.
n/a
Thresholds
€325,881
7 ops.
Buy Volume
€1m
9 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Ypsomed Holding AG Buy (bullish), based on 13 analysts. Average price target: CHF 391.15.
26Σ signal
Buys €325,881€1m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,944 of 29,064 companies
61.1
score / 100
Value
43
Quality
80
FCF yld-0.3%
Earn yld4.2%
EV/EBITDA16.9x
ROE31%
Gross mgn43%
Net mgn30%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 July 2026
Declarations16 total
●
Anonymous (a non-executive member of the board of directors)
a non-executive member of the board of directors·Executives·(filed)
150 shares@ CHF 272.000.0009% mcap100.0% of flowISINISIN CH0019396990SIX:T1N9T00027
16 of 16 declarations
Acerca de Ypsomed Holding AG
Ypsomed Holding AG es una empresa suiza que se especializa en el desarrollo y la fabricación de sistemas de administración de fármacos, particularmente dispositivos de inyección. Se enfoca en soluciones para la diabetes y otras enfermedades crónicas.